Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 May;83(5):1519–1526. doi: 10.1172/JCI114047

Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration.

E N Charlesworth 1, A F Hood 1, N A Soter 1, A Kagey-Sobotka 1, P S Norman 1, L M Lichtenstein 1
PMCID: PMC303856  PMID: 2468688

Abstract

To better define the inflammatory infiltrates and kinetics of mediator release during the cutaneous late-phase reaction (LPR), we examined skin biopsies at 8 h, and skin chamber cell counts and mediator release for 12 h after antigen challenge. Compared with the control sites, the antigen-stimulated biopsy sites contained 14 times as many basophils (P less than 0.01) and six times as many eosinophils (P less than 0.001) with one to two fold more mononuclear cells (P less than 0.03) and neutrophils (P less than or equal to 0.01). Similar changes were found in the skin chambers. Although there were neutrophils in the control chamber, they were only twice as numerous in the antigen challenged site (P less than 0.01). Eosinophils were 35-fold (P less than or equal to 0.03) more prevalent in the antigen chamber than the control chamber for hours 8-12 and basophils were noted starting in the eighth hour and were 20-fold (P less than or equal to 0.03) more concentrated in the antigen chamber during the next 4 h. The mononuclear cells were not significantly different between antigen and control blisters. With respect to inflammatory mediators, there was an initial peak of histamine (13.2 +/- 2.9 ng/ml) in the blister fluid at 1 h. The level then fell to approximately 2 ng/ml, followed by a secondary rise starting at the eighth hour and increasing to 9.8 +/- 2.8 ng/ml by the twelfth hour. This secondary increase in histamine correlated significantly (r = 0.81, P less than 0.05) with the observed influx of basophils. PGD2 in the blister fluid rose to 371+/-25 pg/ml during the first 4 h and then slowly decreased to half this level during the last 4 h. Thus, the cutaneous LPR has been shown to manifest a secondary increase in histamine levels and a markedly specific increase in eosinophils and basophils with mediator release apparently being derived from the latter cells.

Full text

PDF
1519

Images in this article

1521Image
on p.1521
1522Image
on p.1522

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackerman S. J., Loegering D. A., Venge P., Olsson I., Harley J. B., Fauci A. S., Gleich G. J. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J Immunol. 1983 Dec;131(6):2977–2982. [PubMed] [Google Scholar]
  2. Adkinson N. F., Jr Prostaglandin production by human peripheral blood cells in vitro. J Lab Clin Med. 1977 Dec;90(6):1043–1053. [PubMed] [Google Scholar]
  3. Atkins P. C., Zweiman B. The IgE-mediated late-phase skin response--unraveling the enigma. J Allergy Clin Immunol. 1987 Jan;79(1):12–15. doi: 10.1016/s0091-6749(87)80008-8. [DOI] [PubMed] [Google Scholar]
  4. Atkins P., Green G. R., Zweiman B. Histologic studies of human skin test responses to ragweed, compound 48-80, and histamine. J Allergy Clin Immunol. 1973 May;51(5):263–273. doi: 10.1016/0091-6749(73)90128-0. [DOI] [PubMed] [Google Scholar]
  5. Bascom R., Wachs M., Naclerio R. M., Pipkorn U., Galli S. J., Lichtenstein L. M. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol. 1988 Mar;81(3):580–589. [PubMed] [Google Scholar]
  6. Brown M. J., Ind P. W., Causon R., Lee T. H. A novel double-isotope technique for the enzymatic assay of plasma histamine: application to estimation of mast cell activation assessed by antigen challenge in asthmatics. J Allergy Clin Immunol. 1982 Jan;69(1 Pt 1):20–24. doi: 10.1016/0091-6749(82)90082-3. [DOI] [PubMed] [Google Scholar]
  7. Bush R. K., Cohen M. Immediate and late onset asthma from occupational exposure to soybean dust. Clin Allergy. 1977 Jul;7(4):369–373. doi: 10.1111/j.1365-2222.1977.tb01465.x. [DOI] [PubMed] [Google Scholar]
  8. Cowen T., Trigg P., Eady R. A. Distribution of mast cells in human dermis: development of a mapping technique. Br J Dermatol. 1979 Jun;100(6):635–640. doi: 10.1111/j.1365-2133.1979.tb08066.x. [DOI] [PubMed] [Google Scholar]
  9. Davies R. J., Green M., Schofield N. M. Recurrent nocturnal asthma after exposure to grain dust. Am Rev Respir Dis. 1976 Nov;114(5):1011–1019. doi: 10.1164/arrd.1976.114.5.1011. [DOI] [PubMed] [Google Scholar]
  10. Dolovich J., Hargreave F. E., Chalmers R., Shier K. J., Gauldie J., Bienenstock J. Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol. 1973 Jul;52(1):38–46. doi: 10.1016/0091-6749(73)90119-x. [DOI] [PubMed] [Google Scholar]
  11. Dor P. J., Vervloet D., Sapene M., Andrac L., Bonerandi J. J., Charpin J. Induction of late cutaneous reaction by kallikrein injection: comparison with allergic-like late response to compound 48/80. J Allergy Clin Immunol. 1983 Apr;71(4):363–370. doi: 10.1016/0091-6749(83)90063-5. [DOI] [PubMed] [Google Scholar]
  12. Dunsky E. H., Zweiman B. The direct demonstration of histamine release in allergic reactions in the skin using a skin chamber technique. J Allergy Clin Immunol. 1978 Aug;62(2):127–130. doi: 10.1016/0091-6749(78)90091-x. [DOI] [PubMed] [Google Scholar]
  13. Dvoracek J. E., Yunginger J. W., Kern E. B., Hyatt R. E., Gleich G. J. Induction of nasal late-phase reactions by insufflation of ragweed-pollen extract. J Allergy Clin Immunol. 1984 Mar;73(3):363–368. doi: 10.1016/0091-6749(84)90409-3. [DOI] [PubMed] [Google Scholar]
  14. Eady R. A., Cowen T., Marshall T. F., Plummer V., Greaves M. W. Mast cell population density, blood vessel density and histamine content in normal human skin. Br J Dermatol. 1979 Jun;100(6):623–633. doi: 10.1111/j.1365-2133.1979.tb08065.x. [DOI] [PubMed] [Google Scholar]
  15. Fleekop P. D., Atkins P. C., von Allmen C., Valenzano M. C., Shalit M., Zweiman B. Cellular inflammatory responses in human allergic skin reactions. J Allergy Clin Immunol. 1987 Aug;80(2):140–146. doi: 10.1016/0091-6749(87)90122-9. [DOI] [PubMed] [Google Scholar]
  16. Frigas E., Gleich G. J. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol. 1986 Apr;77(4):527–537. doi: 10.1016/0091-6749(86)90341-6. [DOI] [PubMed] [Google Scholar]
  17. Frigas E., Loegering D. A., Solley G. O., Farrow G. M., Gleich G. J. Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc. 1981 Jun;56(6):345–353. [PubMed] [Google Scholar]
  18. Gilbert H. S., Ornstein L. Basophil counting with a new staining method using alcian blue. Blood. 1975 Aug;46(2):279–286. [PubMed] [Google Scholar]
  19. Gleich G. J., Frigas E., Loegering D. A., Wassom D. L., Steinmuller D. Cytotoxic properties of the eosinophil major basic protein. J Immunol. 1979 Dec;123(6):2925–2927. [PubMed] [Google Scholar]
  20. Gleich G. J. The late phase of the immunoglobulin E-mediated reaction: a link between anaphylaxis and common allergic disease? J Allergy Clin Immunol. 1982 Sep;70(3):160–169. doi: 10.1016/0091-6749(82)90037-9. [DOI] [PubMed] [Google Scholar]
  21. Gomez E., Corrado O. J., Baldwin D. L., Swanston A. R., Davies R. J. Direct in vivo evidence for mast cell degranulation during allergen-induced reactions in man. J Allergy Clin Immunol. 1986 Oct;78(4 Pt 1):637–645. doi: 10.1016/0091-6749(86)90082-5. [DOI] [PubMed] [Google Scholar]
  22. Jorgensen H. P., Sondergaard J. Biosynthesis of prostaglandins by human inflamed skin. Acta Derm Venereol. 1976;56(1):11–13. [PubMed] [Google Scholar]
  23. Kalinen M. Hypotheses on the contribution of late-phase allergic responses to the understanding and treatment of allergic diseases. J Allergy Clin Immunol. 1984 Mar;73(3):311–315. doi: 10.1016/0091-6749(84)90401-9. [DOI] [PubMed] [Google Scholar]
  24. Leiferman K. M., Ackerman S. J., Sampson H. A., Haugen H. S., Venencie P. Y., Gleich G. J. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med. 1985 Aug 1;313(5):282–285. doi: 10.1056/NEJM198508013130502. [DOI] [PubMed] [Google Scholar]
  25. MacDonald S. M., Lichtenstein L. M., Proud D., Plaut M., Naclerio R. M., MacGlashan D. W., Kagey-Sobotka A. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol. 1987 Jul 15;139(2):506–512. [PubMed] [Google Scholar]
  26. Marcelo C. L., Voorhees J. J. Cyclic nucleotides, prostaglandins and polyamines in psoriasis. Pharmacol Ther. 1980;9(3):297–310. doi: 10.1016/0163-7258(80)90021-2. [DOI] [PubMed] [Google Scholar]
  27. Metzger W. J., Richerson H. B., Wasserman S. I. Generation and partial characterization of eosinophil chemotactic activity and neutrophil chemotactic activity during early and late-phase asthmatic response. J Allergy Clin Immunol. 1986 Aug;78(2):282–290. doi: 10.1016/s0091-6749(86)80077-x. [DOI] [PubMed] [Google Scholar]
  28. Mitchell E. B., Crow J., Williams G., Platts-Mills T. A. Increase in skin mast cells following chronic house dust mite exposure. Br J Dermatol. 1986 Jan;114(1):65–73. doi: 10.1111/j.1365-2133.1986.tb02780.x. [DOI] [PubMed] [Google Scholar]
  29. Naclerio R. M., Proud D., Togias A. G., Adkinson N. F., Jr, Meyers D. A., Kagey-Sobotka A., Plaut M., Norman P. S., Lichtenstein L. M. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 Jul 11;313(2):65–70. doi: 10.1056/NEJM198507113130201. [DOI] [PubMed] [Google Scholar]
  30. Nagy L., Lee T. H., Kay A. B. Neutrophil chemotactic activity in antigen-induced late asthmatic reactions. N Engl J Med. 1982 Mar 4;306(9):497–501. doi: 10.1056/NEJM198203043060901. [DOI] [PubMed] [Google Scholar]
  31. O'Driscoll B. R., Lee T. H., Cromwell O., Kay A. B. Immunologic release of neutrophil chemotactic activity from human lung tissue. J Allergy Clin Immunol. 1983 Dec;72(6):695–701. doi: 10.1016/0091-6749(83)90632-2. [DOI] [PubMed] [Google Scholar]
  32. Pelikan Z. Late and delayed responses of the nasal mucosa to allergen challenge. Ann Allergy. 1978 Jul;41(1):37–47. [PubMed] [Google Scholar]
  33. Pienkowski M. M., Adkinson N. F., Jr, Plaut M., Norman P. S., Lichtenstein L. M. Prostaglandin D2 and histamine during the immediate and the late-phase components of allergic cutaneous responses. J Allergy Clin Immunol. 1988 Jul;82(1):95–100. doi: 10.1016/0091-6749(88)90057-7. [DOI] [PubMed] [Google Scholar]
  34. Pienkowski M. M., Norman P. S., Lichtenstein L. M. Suppression of late-phase skin reactions by immunotherapy with ragweed extract. J Allergy Clin Immunol. 1985 Nov;76(5):729–734. doi: 10.1016/0091-6749(85)90679-7. [DOI] [PubMed] [Google Scholar]
  35. Robertson D. G., Kerigan A. T., Hargreave F. E., Chalmers R., Dolovich J. Late asthmatic responses induced by ragweed pollen allergen. J Allergy Clin Immunol. 1974 Oct;54(4):244–254. doi: 10.1016/0091-6749(74)90067-0. [DOI] [PubMed] [Google Scholar]
  36. Ruzicka T., Auböck J. Arachidonic acid metabolism in guinea pig Langerhans cells: studies on cyclooxygenase and lipoxygenase pathways. J Immunol. 1987 Jan 15;138(2):539–543. [PubMed] [Google Scholar]
  37. Schulman E. S., Newball H. H., Demers L. M., Fitzpatrick F. A., Adkinson N. F., Jr Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. Am Rev Respir Dis. 1981 Oct;124(4):402–406. doi: 10.1164/arrd.1981.124.4.402. [DOI] [PubMed] [Google Scholar]
  38. Schumacher M. J., Pain M. C. Nasal challenge testing in grass pollen hay fever. J Allergy Clin Immunol. 1979 Sep;64(3):202–208. doi: 10.1016/0091-6749(79)90096-4. [DOI] [PubMed] [Google Scholar]
  39. Shalit M., Campbell D. E., von Allmen C., Atkins P. C., Douglas S. D., Zweiman B. Neutrophil activation in human inflammatory skin reactions. J Allergy Clin Immunol. 1987 Jul;80(1):87–93. doi: 10.1016/s0091-6749(87)80196-3. [DOI] [PubMed] [Google Scholar]
  40. Solley G. O., Gleich G. J., Jordon R. E., Schroeter A. L. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest. 1976 Aug;58(2):408–420. doi: 10.1172/JCI108485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Umemoto L., Poothullil J., Dolovich J., Hargreave F. E. Factors which influence late cutaneous allergic responses. J Allergy Clin Immunol. 1976 Jul;58(1 Pt 1):60–68. doi: 10.1016/0091-6749(76)90107-x. [DOI] [PubMed] [Google Scholar]
  42. Venge P., Dahl R., Håkansson L. Heat-labile neutrophil chemotactic activity in subjects with asthma after allergen inhalation: relation to the late asthmatic reaction and effects of asthma medication. J Allergy Clin Immunol. 1987 Nov;80(5):679–688. doi: 10.1016/0091-6749(87)90287-9. [DOI] [PubMed] [Google Scholar]
  43. Warner J. A., Pienkowski M. M., Plaut M., Norman P. S., Lichtenstein L. M. Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions. J Immunol. 1986 Apr 1;136(7):2583–2587. [PubMed] [Google Scholar]
  44. Zetterström O. Dual skin test reactions and serum antibodies to subtilisin and Aspergillus fumigatus extracts. Clin Allergy. 1978 Jan;8(1):77–91. [PubMed] [Google Scholar]
  45. Zweiman B., Slott R. I., Atkins P. C. Histologic studies of human skin test responses to ragweed and compound 48/80. III. Effects of alternate-day steroid therapy. J Allergy Clin Immunol. 1976 Dec;58(6):657–663. doi: 10.1016/0091-6749(76)90177-9. [DOI] [PubMed] [Google Scholar]
  46. deShazo R. D., Levinson A. I., Dvorak H. F., Davis R. W. The late phase skin reaction: evidence for activation of the coagulation system in an IgE-dependent reaction in man. J Immunol. 1979 Feb;122(2):692–698. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES